CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,714 shares (to pay taxes)
- 4 Grant or award Chief Legal Officer acquired 100,000 shares (grant or award)
- 4 Planned sale President and CEO sold 8,257 shares at $4.29 ($35,413)
- 4 Shares withheld for taxes SVP, Regulatory Affairs gave up 1,667 shares (to pay taxes)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Agreement ended · Results of operations · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- 4 Shares withheld for taxes Corporate Secretary gave up 135,690 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 56,778 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 335,922 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 92,652 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 72,734 shares (to pay taxes)
- 4 Shares withheld for taxes Corporate Secretary gave up 76,147 shares (to pay taxes)
Page 3 of 35 · 689 filings